Neuren Pharmaceuticals
NEU.AX
#5836
Rank
A$1.26 B
Marketcap
$9.86
Share price
-6.72%
Change (1 day)
-51.26%
Change (1 year)

EPS for Neuren Pharmaceuticals (NEU.AX)

EPS in 2023: $1.38

According to Neuren Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.38. In 2023 the company made an earnings per share (EPS) of $1.38 an increase over its 2022 EPS that were of $0.001678.

EPS history for Neuren Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.3882396.45%
2022$0.001678-102.13%
2021-$0.07867-27.64%
2020-$0.11-12.55%
2019-$0.12-446.24%
2018$0.03590-247.23%
2017-$0.02439-85.3%
2016-$0.17-13.42%
2015-$0.1934.36%
2014-$0.14-47.14%
2013-$0.2783.64%
2012-$0.15-28.56%
2011-$0.21-46.5%
2010-$0.38-3690.16%
2009$0.01071-100.76%
2008-$1.41-38.72%
2007-$2.3011.23%
2006-$2.0614.27%
2005-$1.81-42.59%
2004-$3.152.56%
2003-$3.0736.5%
2002-$2.25